Canadian Online Pharmacy

CDER New May 23, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

May 22, 2013

 


New and Generic Drug Approvals

May 21, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Cuvposa glycopyrrolate Solution; Oral Merz Pharms Labeling Revision
Dopamine Hydrochloride In Dextrose 5% In Plastic Container dopamine hydrochloride Injectable; Injection Baxter Hlthcare Manufacturing Change or Addition
Lanoxin digoxin Tablet; Oral Covis Pharma Manufacturing Change or Addition
Methergine methylergonovine maleate Injectable; Injection Us Pharms Holdings I Manufacturing Change or Addition
Methergine methylergonovine maleate Tablet; Oral Us Pharms Holdings I Manufacturing Change or Addition
Optimark gadoversetamide Injectable; Injection Mallinckrodt Labeling Revision
Optimark gadoversetamide Injectable; Injection Mallinckrodt Labeling Revision
Optimark In Plastic Container gadoversetamide Injectable; Injection Mallinckrodt Labeling Revision
Razadyne galantamine hydrobromide Tablet; Oral Janssen Pharms Manufacturing Change or Addition
Razadyne galantamine hydrobromide Solution; Oral Janssen Pharms Manufacturing Change or Addition
Razadyne Er galantamine hydrobromide Capsule, Extended Release; Oral Janssen Pharms Manufacturing Change or Addition
Stelara ustekinumab Injectable; Injection Centocor Ortho Biotech Inc Efficacy Supplement with Clinical Data to Support
Sumatriptan Succinate sumatriptan succinate Tablet; Oral Hikma Pharms Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery